Representative before the EPO

Employment test 51 - 200 employees
Company dna mewburn ellis llp
operating since 1890
Headquarter in London and 4 offices
active in Legal Services

Emily Anne Luxford Hayes has worked on the following 29 EPO patent applications which have been published in the last five years:

EP12179244

KLOTHO-BETA FOR USE IN TREATING CANCER, LIVER DISORDERS, GALLSTONES, WASTING SYNDROME AND OBESITY-RELATED DISEASES

IPC classification:
A61K 38/17, A61P 1/16, A61P 3/04, A61P 3/06, A61P 3/10, A61P 9/00, A61P 9/12, A61P 11/00, A61P 35/00, G01N 33/74
Applicant:
Genentech, Inc.
Agent:
Emily Anne Luxford Hayes, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12725893

METHOD AND COMPOSITIONS FOR CELLULAR IMMUNOTHERAPY

IPC classification:
A61P 35/00, C07K 14/705, C07K 16/28, C07K 16/30, C12N 5/0783
Agent:
Emily Anne Luxford Hayes, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12796309

METHODS FOR REPAIRING TISSUE DAMAGE USING PROTEASE-RESISTANT MUTANTS OF STROMAL CELL DERIVED FACTOR-1

IPC classification:
A61K 38/00
Agent:
Emily Anne Luxford Hayes, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11770502

MALARIA VACCINE

IPC classification:
A61K 39/015, C07K 16/20
Agent:
Emily Anne Luxford Hayes, Mewburn Ellis LLP
Agent:
Robert John Stephen, Olswang LLP
Status:
EXAMINATION IN PROGRESS
EP13189438

Products and methods for stimulating an immune response

IPC classification:
A61K 39/00, A61K 39/385, A61K 39/39
Agent:
Emily Anne Luxford Hayes, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP13189439

Products and methods for stimulating an immune response

IPC classification:
A61K 39/00, A61K 39/385, A61K 39/39
Agent:
Emily Anne Luxford Hayes, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12784833

GENETICALLY MODIFIED T CELL RECEPTOR MICE

IPC classification:
A01K 67/027, C07K 14/705
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Emily Anne Luxford Hayes, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12787255

GENETICALLY MODIFIED MAJOR HISTOCOMPATIBILITY COMPLEX MICE

IPC classification:
A01K 67/027
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Emily Anne Luxford Hayes, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12806199

TRANSGENIC MICE EXPRESSING CHIMERIC MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) CLASS II MOLECULES

IPC classification:
A01K 67/027, C07K 14/705
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Emily Anne Luxford Hayes, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11766744

METHODS FOR THE TREATMENT OF AUTOIMMUNE DISEASES

IPC classification:
A61K 39/00, A61K 39/04, C12N 15/86
Applicant:
The General Hospital Corporation
Agent:
Emily Anne Luxford Hayes, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14179247

Gene expression and pain

IPC classification:
A61K 48/00, C07H 21/04, C12N 15/113
Agent:
Emily Anne Luxford Hayes, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12777107

COMPOSITIONS AND METHOD FOR TREATING AUTOIMMUNE DISEASES

IPC classification:
C07K 16/24
Applicant:
Genentech, Inc.
Agent:
Emily Anne Luxford Hayes, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13725429

METHODS AND GROUPS

IPC classification:
A61K 38/14, C12Q 1/04
Agent:
Emily Anne Luxford Hayes, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14189442

Multivalent antibodies and uses therefor

IPC classification:
A61K 39/395, A61K 47/48, A61K 51/10, C07K 16/00, C07K 16/28, C07K 16/30, C07K 16/32, C07K 19/00, C12N 5/10, C12N 15/13, C12N 15/62
Applicant:
Genentech, Inc.
Agent:
Emily Anne Luxford Hayes, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP13731479

METHOD FOR REPROGRAMMING SOMATIC CELLS TO PANCREATIC BETA-CELLS

IPC classification:
C12N 5/071, C12N 5/10, C12N 15/85, G01N 33/50
Applicant:
Cancer Research Technology Ltd
Agent:
Emily Anne Luxford Hayes, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14748807

METHODS FOR EXPANSION OR DEPLETION OF T-REGULATORY CELLS

IPC classification:
A61K 35/12, A61K 39/00, C12N 5/10
Applicant:
The General Hospital Corporation
Agent:
Emily Anne Luxford Hayes, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14708429

MICE EXPRESSING HUMANIZED MAJOR HISTOCOMPATIBILITY COMPLEX

IPC classification:
A01K 67/027, C07K 14/705, C07K 14/73, C07K 14/74, C12N 15/85
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Emily Anne Luxford Hayes, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14708430

MICE EXPRESSING HUMANIZED T-CELL CO-RECEPTORS

IPC classification:
A01K 67/027, C07K 14/705, C07K 14/73, C12N 15/85
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Emily Anne Luxford Hayes, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14718815

TRANSGENIC MICE EXPRESSING CHIMERIC MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) CLASS II MOLECULES

IPC classification:
A01K 67/027, C07K 14/74
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Emily Anne Luxford Hayes, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14718226

TRANSGENIC MICE EXPRESSING CHIMERIC MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) CLASS I MOLECULES

IPC classification:
A01K 67/027
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Emily Anne Luxford Hayes, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14713567

DIAGNOSTIC AND PROGNOSTIC BIOMARKERS FOR PROSTATE CANCER AND OTHER DISORDERS

IPC classification:
C12Q 1/68
Applicant:
Cancer Research Technology Ltd
Agent:
Emily Anne Luxford Hayes, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14806816

ANALOGS OF PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) AND METHODS FOR THEIR USE

IPC classification:
A61K 38/00, A61P 35/00
Agent:
Emily Anne Luxford Hayes, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12179717

Methods for dectecting autoimmune disorders

IPC classification:
C12Q 1/68
Applicant:
Genentech, Inc.
Agent:
Emily Anne Luxford Hayes, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP16157878

GENETICALLY MODIFIED MICE AND ENGRAFTMENT

IPC classification:
A01K 67/027, A61K 49/00, C07K 14/52, C07K 14/535, C07K 14/54, C07K 14/715, C12N 9/00
Applicant:
Regeneron Pharmaceuticals Inc
Applicant:
Yale University
Agent:
Emily Anne Luxford Hayes, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP16161227

NEUTRALIZING HUMAN ANTIBODY MOLECULES FOR IL-13

IPC classification:
A61K 39/00, A61K 39/395, A61P 11/06, A61P 35/00, C07K 16/24, C12N 15/13
Agent:
Emily Anne Luxford Hayes, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14869229

METHODS FOR REPAIRING TISSUE DAMAGE USING PROTEASE-RESISTANT MUTANTS OF STROMAL CELL DERIVED FACTOR-1

IPC classification:
A61K 38/19
Agent:
Emily Anne Luxford Hayes, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15832083

OLIGONUCLEOTIDE DECOYS FOR THE TREATMENT OF PAIN

IPC classification:
A61K 31/7088, A61P 25/04, C12N 15/113
Agent:
Emily Anne Luxford Hayes, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15775854

CHIMERIC ANTIGEN RECEPTORS

IPC classification:
A01K 67/027, C07K 14/725, C07K 16/00, C07K 19/00
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Emily Anne Luxford Hayes, Mewburn Ellis LLP
Status:
Request for examination was made
EP16199871

GENE EXPRESSION AND PAIN

IPC classification:
A61K 48/00, C07H 21/04, C12N 15/113
Agent:
Emily Anne Luxford Hayes, Mewburn Ellis LLP
Status:
The application has been published

Please Sign in to use this feature